8-pyridazinylcarbamoyl ergolines
    1.
    发明授权
    8-pyridazinylcarbamoyl ergolines 失效
    8-哒嗪基氨基甲酰基麦角碱

    公开(公告)号:US4675404A

    公开(公告)日:1987-06-23

    申请号:US885315

    申请日:1986-07-14

    CPC分类号: C07D457/06 C07D457/02

    摘要: Ergoline derivatives of formula: ##STR1## wherein n=0,1,2; R.sub.1 =H, CH.sub.3 ; R.sub.2 =H, CH.sub.3, halogen; R.sub.3 =H, OCH.sub.3 ; R.sub.4 =hydrocarbon group and R.sub.5 is a residue of general formula II, III, IV, V, VI, VII: ##STR2## wherein R.sub.6 =H, Cl, OCH.sub.3, NR.sub.11 R.sub.12, wherein R.sub.11 and R.sub.12 =H, lower alkyl; phenyl or are bonded together to form a heterocyclic ring, R.sub.7, R.sub.8 and R.sub.9 and R.sub.10 =H or C.sub.1 -C.sub.3 alkyl, with the proviso that if R.sub.5 is of formula II and R.sub.2 =R.sub.7 =R.sub.8 =H, then R.sub.4 is not methyl or n is not 0.Pharmaceutically acceptable acid addition salts are also provided. A method for their preparation is also provided.The compounds have anti-depressive, anti-hypertensive and antiprolactin activity.

    摘要翻译: 式:其中n = 0,1,2; R1 = H,CH3; R2 = H,CH3,卤素; R3 = H,OCH3; R4 =烃基,R5是通式Ⅱ,Ⅲ,Ⅳ,Ⅴ,Ⅵ,Ⅶ的残基:其中R6 = H,Cl,OCH3,NR11R12,其中R11和R12 = H,低级烷基; 苯基或键合在一起形成杂环,R 7,R 8和R 9和R 10 = H或C 1 -C 3烷基,条件是如果R 5为式II且R 2 = R 7 = R 8 = H,则R 4不是甲基 或n不为0.还提供药学上可接受的酸加成盐。 还提供了它们的制备方法。 该化合物具有抗抑郁,抗高血压和抗催乳素活性。